why choose us

First received: June 06, 2024

Clinical Trial: Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Meningioma of Brain

Study Type: OBSERVATIONAL


Official Title: Tumor Absorbed Dose-Response Relationship in Patients Treated With 177Lu-DOTATATE for Meningioma

Brief Summary: The hypothesis for this study is that there is a dose-response relationship in patients treated with 177Lu-DOTATATE for meningiomas.

Read more